Your browser doesn't support javascript.
loading
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars.
Barbier, Liese; Declerck, Paul; Simoens, Steven; Neven, Patrick; Vulto, Arnold G; Huys, Isabelle.
Afiliação
  • Barbier L; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. liese.barbier@kuleuven.be.
  • Declerck P; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Neven P; Department of Oncology, UZ Leuven, Leuven, Belgium.
  • Vulto AG; Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Huys I; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Br J Cancer ; 121(3): 199-210, 2019 07.
Article em En | MEDLINE | ID: mdl-31257362
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Trastuzumab / Anticorpos Monoclonais / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Trastuzumab / Anticorpos Monoclonais / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica